Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2024 08:00 ET | Source: Insignis Therapeutics, Inc.

Insignis Therapeutics Announces Positive Results from Phase 1 Clinical Study of IN-001 Liquid Epinephrine Sublingual Spray for Anaphylaxis

Insignis' Phase 1 trial shows IN-001 spray quickly reaches target epinephrine levels, sustained for 2 hours, offering a reliable needle-free alternative.
August 19, 2024 05:12 ET | Source: Research and Markets

Epinephrine Auto-Injection Market Report 2024-2029: Increasing Demand at Pharma/Retail stores, Customization and Personalization, and Rise of Generic Epinephrine Auto-injectors

Dublin, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The "Epinephrine Auto-Injection Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Epinephrine...
August 13, 2024 07:30 ET | Source: Insignis Therapeutics, Inc.

Insignis Therapeutics Receives FDA Fast Track Designation for IN-001 for Anaphylaxis Treatment

Insignis’ liquid epinephrine sublingual spray for anaphylaxis, stable and usable under both extreme heat and cold, gains FDA Fast Track designation.
March 05, 2019 05:30 ET | Source: CampDoc.com

CampDoc Launches Discounted Epinephrine Auto-Injector Pricing Program for Camps

ANN ARBOR, Mich., March 05, 2019 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps, announced the launch of CampEpi, a new program offering discounted epinephrine...
September 06, 2018 09:18 ET | Source: Aterica Inc.

Aterica Digital Health Announces Availability of its Veta™ Smart Case & App for Epinephrine Auto-Injectors (such as EPIPEN® auto-injectors)

WATERLOO, Ontario, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Aterica Inc., a consumer-focused digital health company, today announces the general availability of Veta™ Smart Case & App – the first-ever...
October 09, 2017 03:00 ET | Source: Allergy Partners

Anaphylaxis and the Importance of Always Having an EpiPen

ASHEVILLE, N.C., Oct. 09, 2017 (GLOBE NEWSWIRE) -- EpiPen and EpiPen Jr are injectable forms of epinephrine used to treat anaphylaxis, which is a severe form of an allergic reaction. Anaphylaxis is...
August 28, 2017 10:15 ET | Source: London Drugs Ltd.

Study: Fewer than half of children with severe allergies receive life-saving epinephrine

RICHMOND, British Columbia, Aug. 28, 2017 (GLOBE NEWSWIRE) -- When children with life threating allergies experience anaphylaxis, parents, teachers and other caregivers often fail to administer...